Sexual health prevention has changed a lot in the last few years. Most people are familiar with condoms, routine STI testing, and PrEP for HIV prevention. But there is now another tool available that many people have never heard of: DoxyPEP. It stands for doxycycline post-exposure prophylaxis, and it’s an evidence-based strategy to reduce the risk of certain bacterial sexually transmitted infections after sex.

DoxyPEP involves taking a single dose of the antibiotic doxycycline within 72 hours after condomless sex to help prevent infections like chlamydia, syphilis, and in some cases gonorrhea. The idea is similar to how emergency contraception works for pregnancy or how HIV PEP works after a high-risk exposure. Instead of waiting to see if symptoms develop, DoxyPEP aims to stop an infection before it has a chance to take hold.

This approach isn’t experimental anymore. It’s supported by solid research. A major randomized clinical trial published in the New England Journal of Medicine in 2023 studied men who have sex with men and transgender women who were at higher risk for STIs. Participants who used doxycycline as post-exposure prevention had significantly lower rates of chlamydia and syphilis compared to those who did not. The study showed about a two-thirds reduction in new STI infections overall, making DoxyPEP one of the most promising new prevention tools in sexual health.

DoxyPEP does not prevent everything. It does not protect against HIV, herpes, HPV, or other viral infections. Its main strength is reducing bacterial STIs, especially chlamydia and syphilis, which have been rising steadily in many parts of the U.S., including California. Protection against gonorrhea is more variable because some strains are resistant to doxycycline, but even there, many people still see meaningful benefit.

The way DoxyPEP is used is straightforward. After a potential exposure, a person takes 200 mg of doxycycline (usually two 100-mg pills) as soon as possible, ideally within 24 hours, and no later than 72 hours. It is not meant to be taken every day like PrEP. Instead, it is used only when needed, making it a flexible option for people who have occasional higher-risk encounters.

Not everyone needs DoxyPEP. It is generally recommended for people who are at increased risk for STIs, such as those with multiple partners, people already using HIV PrEP, or individuals who have had a recent bacterial STI. A clinician can help determine whether it makes sense for your personal situation based on your history and risk level.

Like any medication, doxycycline can have side effects. The most common are mild stomach upset, heartburn, or sensitivity to sunlight. These are usually manageable and temporary. More serious side effects are uncommon when the medication is used appropriately. Concerns about antibiotic resistance are important, which is why DoxyPEP is recommended selectively rather than for everyone.

It’s also important to understand what DoxyPEP is not. It is not a replacement for condoms, regular STI screening, or honest conversations with partners. Think of it as an additional layer of protection, another tool in the sexual health toolbox. Many people choose to combine PrEP for HIV prevention with DoxyPEP for bacterial STI prevention to create a more complete strategy.

Access to DoxyPEP is easier than many people realize. Through telehealth, a licensed clinician can review your medical history, discuss your risk factors, and prescribe it when appropriate. The goal is not to judge anyone’s choices, but to reduce harm and keep people healthy.

Sexual health is about being informed, prepared, and proactive. DoxyPEP gives people more control and more options than ever before. If you’ve been looking for a practical way to lower your STI risk, this could be a smart step worth considering.